Abstract:Dissecting large bulk RNA-seq data into cell proportions and cell type specific expression profiles could significantly enhance our understanding of disease mechanisms at cell level and facilitate the identification of novel drug targets and development of efficient intervention strategies. In this study, we presented a scRNA-seq marker (gene) informed cell deconvolution and expression inference (CausalCellInfer) framework. CausalCellInfer employed causal inference principles to automatically identify a small set of critical marker genes from the reference scRNA-seq dataset. It then integrates deep neural networks with regularized matrix completion algorithms to deconvolute cell proportions and estimate cell type specific (CTS) expression profiles. Most importantly, we pioneered the application of the proposed framework to imputed expression data from large-scale genome-wide association studies (GWAS). We verified the efficacy of our proposed method by comparing it against existing state-of-the-art cell deconvolution methods, including CIBERSORTx, DWLS, Scaden, and MuSic across various real and pseudo-bulk samples. Furthermore, we proposed the use of a wide range of enrichment analyses to demonstrate the reliability of CausalCellInfer in estimating CTS profiles. Our proposed framework consistently outperformed existing methods with significantly higher concordance correlation coefficient (CCC), lower mean absolute error (MAE) and root mean square error (RMSE) across all testing real and pseudo bulk samples. Importantly, it also demonstrated superior computational efficiency compared to all benchmarked methods except MuSic. We also applied our trained models to deconvolute 4 tissue-specific expression cell proportions and estimate the corresponding CTS expression profiles, leveraging UK Biobank data (UKBB). We conducted a series of cellular-level analyses, including cell proportion association analysis, causal gene detection, transcriptome wide association analysis (TWAS), for 24 phenotypes in UKBB based on estimated cell composition and CTS expression profiles. Of note, the estimated proportions of various cell types were indicative of disease onset. For example, T2DM patients demonstrated a significant decrease in the proportions of alpha and beta cells in comparison to controls. We also tested their associations. Our method exhibited satisfactory positive predictive values (PPV) in uncovering differentially expressed (DE) genes for the majority of cell types. Encouragingly, most identified CTS causally relevant genes were found to be significantly enriched in target diseases or related pathophysiology. In conclusion, we presented a novel framework for inferring cell-type proportions and CTS expression, with novel applications to GWAS-imputed expression data from large-scale biobank program. Our work also shed light on how differential cell-type proportion and CTS expression may be associated with susceptibility to different diseases and their prognoses, bridging scRNA-seq and clinical phenotypes in large-scale biobank studies.

Revealing brain cell-stratified causality through dissecting causal variants according to their cell-type-specific effects on gene expression

Inferring causal cell types of human diseases and risk variants from candidate regulatory elements

An augmented Mendelian randomization approach provides causality of brain imaging features on complex traits in a single biobank-scale dataset

Estimating cell compositions and cell-type-specific expressions from GWAS data using invariant causal prediction, deep learning and regularized matrix completion

An analytical method for the identification of cell type-specific disease gene modules

Inferring Multi-Organ Genetic Causal Connections using Imaging and Clinical Data through Mendelian Randomization

Single-cell transcriptome-wide Mendelian randomization and colocalization analyses uncover cell-specific mechanisms in atherosclerotic cardiovascular disease

Single-Nucleus Atlas of Cell-Type Specific Genetic Regulation in the Human Brain

Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics

Mendelian randomization accounting for complex correlated horizontal pleiotropy while elucidating shared genetic etiology

Single-cell genomics improves the discovery of risk variants and genes of cardiac traits

Disentangling associations between complex traits and cell types with

Inferring the Genetic Relationship Between Brain Imaging-Derived Phenotypes and Risk of Complex Diseases by Mendelian Randomization and Genome-Wide Colocalization.

Applying causal discovery to single-cell analyses using CausalCell

Systematic comparative analysis of Mendelian randomization methods for inferring causal genes of complex phenotypes and the application to psychiatric diseases

A Global Overview of Single-Cell Type Selectivity and Pleiotropy in Complex Diseases and Traits

Leveraging single-cell ATAC-seq and RNA-seq to identify disease-critical fetal and adult brain cell types

The potential clinical impact of cell type-specific genetic regulation: Crohn's disease

Genetic regulation of cell type–specific chromatin accessibility shapes brain disease etiology

Discovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens

A unified framework for cell-type-specific eQTLs prioritization by integrating bulk and scRNA-seq data